Valuation: IRADIMED CORPORATION

Market Cap 1.17B 1.02B 948M 872M 1.65B 112B 1.67B 11.14B 4.37B 55.88B 4.41B 4.31B 185B P/E 2026 *
47.8x
P/E 2027 * 41.4x
Enterprise Value 1.17B 1.02B 948M 872M 1.65B 112B 1.67B 11.14B 4.37B 55.88B 4.41B 4.31B 185B EV / Sales 2026 *
12.9x
EV / Sales 2027 * 11.6x
Free-Float
64.81%
Yield 2026 *
-
Yield 2027 * -
1 day-1.36%
1 week-2.55%
Current month+1.10%
1 month-9.02%
3 months+6.99%
6 months-2.83%
Current year-5.57%
1 week 89.51
Extreme 89.51
97.74
1 month 89.51
Extreme 89.51
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 67.51
Extreme 67.51
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
30/3/26 Sell

Chief Executive Officer

7,500 0.0590%
13/2/26 Sell

Director

1,000 0.0079%
26/1/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-2.55%+32.04%+89.71% 1.19B
-1.30%-0.92%-12.15%-16.57% 13.9B
+3.87%+4.46%+48.05%-2.62% 4.02B
-0.82%+5.74%-36.89%-52.60% 1.31B
-3.13%+8.48%-33.24%-40.07% 1.27B
-1.11%+2.71%-45.72% - 972M
+14.85%+16.29%+30.56%+126.54% 472M
-2.45%+2.11%+63.53% - 347M
-0.55%+5.02%-62.15%+227.45% 258M
0.00%+25.97%+29.44%+63.37% 161M
Average +0.80%+7.46%+1.35%+49.40% 2.39B
Weighted average by Cap. -0.18%+1.56%-1.97%-5.53%

Financials

2026 *2027 *
Net sales 91.2M 78.99M 73.63M 67.72M 128M 8.67B 129M 865M 340M 4.34B 343M 335M 14.37B 101M 87.48M 81.54M 75M 142M 9.6B 143M 958M 376M 4.81B 379M 371M 15.91B
Net income 24.65M 21.35M 19.9M 18.3M 34.56M 2.34B 34.94M 234M 91.79M 1.17B 92.58M 90.54M 3.88B 28.45M 24.64M 22.97M 21.13M 39.88M 2.71B 40.33M 270M 106M 1.35B 107M 104M 4.48B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
05/08/26 USD 91.86 -1.36% 148,482
04/08/26 USD 93.13 +1.71% 227,288
03/08/26 USD 91.56 +0.77% 214,735
31/07/26 USD 90.86 -4.57% 308,081
30/07/26 USD 95.21 +1.01% 122,193
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
91.86USD
Average target price
118.00USD
Spread / Average Target
+28.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock